Story

On air. The free wire runs 15 minutes behind live. See pricing

World, crypto, finance and tech news, scored for impact.

MarketsSEC EDGAR SCHEDULE 13GFiled 3 days ago

Definium Therapeutics, Inc.: Capital World Investors discloses a stake of more than 5% (Schedule 13G)

Open the sourceReported by SEC EDGAR SCHEDULE 13G, sec.gov, 13 November 2026, by SEC EDGAR SCHEDULE 13G

Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.

Capital World Investors disclosed a stake exceeding 5% in Definium Therapeutics, Inc. via a Schedule 13G filing with the SEC (accession 0001422849-26-000171). The exact share count and percentage were not specified in the filing headline. The disclosure signals that a major institutional investor has built a significant position in the company. Investors will watch for further detail on the size and nature of the holding, and whether Capital World increases or adjusts its stake in future filings.

Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.

Named in this story

Definium Therapeutics, Inc., Capital World Investors